Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by mjn797979on Jun 29, 2020 1:14pm

63 Views

Post# 31203773

RE:RE:RE:RE:RE:RE:RE:RE:RE:Goodman Needs to be more Aggressive

You are right, there are always the ones that bought higher and at a loss.
I was just comparing the returns with GUD.
I unfortunately have an average price of 7.95$ which I find low but now with price under 7$, its a bit discouraging, especially after all these years.
I truly hope there can be some good news this year, I was not expecting this to ever see under 7$ again especially with the acquisition.
Most people thought we would be over 10$ in 2020 but not the case.
Anyways, im not blaming anyone, I decided to buy GUD as a long term play.

Bullboard Posts

Two micro-cap stocks with strong fundamentals